Last update 19 Nov 2026

Anakinra (Amgen)

Overview

Basic Info

Drug Type
Interleukins
Synonyms
anakinra, Anakinra (Amgen/SOBI), Anakinra (USAN/INN)
+ [9]
Target
Action
antagonists
Mechanism
IL1R1 antagonists(Interleukin-1 receptor alpha antagonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (14 Nov 2001),
RegulationEmergency Use Authorization (United States), Orphan Drug (United States), Priority Review (China), Orphan Drug (Japan)
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Deficiency of Interleukin-1 Receptor Antagonist
United States
18 Dec 2020
COVID-19
European Union
08 Mar 2002
COVID-19
Iceland
08 Mar 2002
COVID-19
Liechtenstein
08 Mar 2002
COVID-19
Norway
08 Mar 2002
Cryopyrin-Associated Periodic Syndromes
European Union
08 Mar 2002
Cryopyrin-Associated Periodic Syndromes
Iceland
08 Mar 2002
Cryopyrin-Associated Periodic Syndromes
Liechtenstein
08 Mar 2002
Cryopyrin-Associated Periodic Syndromes
Norway
08 Mar 2002
Familial cold urticaria
European Union
08 Mar 2002
Familial cold urticaria
Iceland
08 Mar 2002
Familial cold urticaria
Liechtenstein
08 Mar 2002
Familial cold urticaria
Norway
08 Mar 2002
Familial Mediterranean Fever
European Union
08 Mar 2002
Familial Mediterranean Fever
Iceland
08 Mar 2002
Familial Mediterranean Fever
Liechtenstein
08 Mar 2002
Familial Mediterranean Fever
Norway
08 Mar 2002
Muckle-Wells Syndrome
European Union
08 Mar 2002
Muckle-Wells Syndrome
Iceland
08 Mar 2002
Muckle-Wells Syndrome
Liechtenstein
08 Mar 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mucocutaneous Lymph Node SyndromePhase 3
France
20 Oct 2023
InflammationPhase 3
United States
02 Apr 2020
InflammationPhase 3
Italy
02 Apr 2020
Respiratory Distress SyndromePhase 3
United States
02 Apr 2020
Respiratory Distress SyndromePhase 3
Italy
02 Apr 2020
Cystitis, InterstitialPhase 2
Sweden
22 Apr 2022
B-Cell LymphomaPhase 2
United States
27 Dec 2021
Carney ComplexPhase 2
United States
27 Dec 2021
Neurotoxicity SyndromesPhase 2
United States
27 Dec 2021
Cytokine Release SyndromePhase 2
United States
01 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
61
Anakinra 100mg twice daily between days 2 and 10
hyqmhitrri(nlkvghgkhp): OR = 2.67 (95.0% CI, 1.04 - 6.81), P-Value = 0.04
Positive
12 Dec 2026
Anakinra 100mg daily between days 0 and 7
Phase 2/3
73
zhgbncoqqi(agqfbqeqkj) = ywbmiklrmw uxlwshkaes (fswtplqdnm )
Negative
01 Dec 2026
Not Applicable
3,060
fzqthslfbr(bqwiipsjxn) = vckzqtomjc camjitsohe (qdhfvmhuul, 30.0)
Positive
06 Nov 2026
Not Applicable
150
hdrcedhsze(emlidxzsiv) = edqzwgclur xtzbxotzht (terdhpnafn )
Positive
06 Nov 2026
hdrcedhsze(emlidxzsiv) = rrmlkahowk xtzbxotzht (terdhpnafn )
Not Applicable
21
dsnosowlrj(iybvkkjklw) = occurred in only 1 (5%) patient urfkcbfsvg (yowmfreebj )
Positive
23 Sep 2026
Not Applicable
20
wjvrcrnreg(gjypquzxwm) = Two patients developed mild injection-site reactions, and 1 died due to sepsis. zeqrdibyvn (syccdtvvvi )
Positive
11 Jun 2026
Not Applicable
76
smonoqjmbj(ahlybxherr) = bmaqcpfwpm lfyqbkvdsp (enofgfjtrb )
Positive
11 Jun 2026
smonoqjmbj(rmpzcvrhkg) = dklkljjhsy bquyxikrwc (brnifwpucq )
Not Applicable
30
xjtdhceecy(oxikfgbcfv) = uuaqdgavfd mneuzgomcm (ifzrffdncp )
Positive
11 Jun 2026
Not Applicable
13
ywcvpbwuyi(elrgwmdotu) = frpfeusyff itivcyghiv (fqrpplxylv )
Positive
11 Jun 2026
Not Applicable
92
Intravenous steroids
wbspzckiol(jmprnejgdh) = lmyzpmukro lzudbquvji (zgfurozwlu )
Positive
11 Jun 2026
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free